K2 Principal Fund, L.P. Bristol Myers Squibb CO Put Options Transaction History

K2 Principal Fund, L.P.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $26.1 Million - $30 Million	-435,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $18 Million - $19.6 Million	300,000 Added 222.22%	435,000 $26.7 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $7.46 Million - $8.6 Million	135,000	135,000 $8.61 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.